Internal Medicine, Interventional Cardiology · Lincoln, NE
NPI
1972523983
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
7440 S 91st St
Lincoln, NE, 68526
Phone (402) 489-6555
Groups this clinician bills Medicare through
Medicare paid, 2024
$390K
6,987 services
Medicare patients, 2024
1,294
Average age 77
Drug cost, 2024
$754K
7,916 prescriptions
Company payments, 2025
$3,439
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harpaul Bajwa was code 99214 (office e&m - established), 1,020 times for 456 patients. In total Harpaul Bajwa billed 6,987 services in 88 codes, and Medicare paid $390K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,020 | 456 | $66.11 | $67K |
| 99214 Office E&M - Established | Office | 926 | 481 | $79.13 | $73K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 372 | 44 | $48.06 | $18K |
| 93000 Electrocardiogram | Office | 348 | 313 | $8.90 | $3,097 |
| 93296 External Electrocardiographic Monitoring | Office | 285 | 115 | $14.07 | $4,010 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 282 | 70 | $5.55 | $1,564 |
| 93294 External Electrocardiographic Monitoring | Office | 281 | 100 | $19.97 | $5,611 |
| 93306 Echocardiography (TTE/TEE) | Facility | 261 | 254 | $48.60 | $13K |
| 93306 Echocardiography (TTE/TEE) | Office | 236 | 229 | $127.86 | $30K |
| 93297 External Electrocardiographic Monitoring | Office | 226 | 53 | $40.68 | $9,195 |
| 36415 Venipuncture Blood Collection | Office | 204 | 139 | $8.65 | $1,765 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 197 | 99 | $69.92 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 158 | 80 | $57.17 | $9,032 |
| 99457 E&M - Miscellaneous | Office | 136 | 33 | $37.78 | $5,138 |
| 93010 Electrocardiogram | Facility | 119 | 97 | $5.77 | $686 |
By year: 2022 $373K for 5,890 services; 2023 $411K for 6,728 services; 2024 $390K for 6,987 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 204 | 139 | $8.65 | $1,765 |
| 80048 Clinical Chemistry | 118 | 71 | $8.29 | $978 |
| 80061 Clinical Chemistry | 82 | 70 | $13.12 | $1,076 |
| 83880 Clinical Chemistry | 65 | 38 | $38.47 | $2,501 |
| 85027 Blood Count | 51 | 41 | $6.34 | $323 |
| 80053 Clinical Chemistry | 13 | 12 | $10.35 | $135 |
Medicare prescription drug claims, 2024
In 2024, the drug Harpaul Bajwa prescribed most often to Medicare patients was Rosuvastatin Calcium, with 911 prescriptions and refills. In total Harpaul Bajwa wrote 7,916 Medicare prescriptions that cost $754K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 911 | 2,148 | 259 | $8,257 |
| Amlodipine Besylate Generic | 563 | 1,216 | 146 | $2,684 |
| Metoprolol Succinate Generic | 479 | 1,167 | 141 | $6,802 |
| Ezetimibe Generic | 469 | 1,085 | 131 | $9,097 |
| Lisinopril Generic | 462 | 1,152 | 138 | $2,599 |
| Atorvastatin Calcium Generic | 388 | 1,018 | 117 | $3,569 |
| Carvedilol Generic | 336 | 775 | 94 | $1,737 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 303 | 758 | 87 | $5,481 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 296 | 677 | 81 | $1,634 |
| Furosemide Generic | 296 | 547 | 87 | $1,196 |
| Losartan Potassium Generic | 289 | 636 | 80 | $2,820 |
| Eliquis Apixaban | 283 | 447 | 64 | $246K |
| Clopidogrel Clopidogrel Bisulfate | 280 | 635 | 86 | $2,563 |
| Labetalol Hcl Generic | 244 | 492 | 54 | $11K |
| Amiodarone Hcl Generic | 182 | 378 | 52 | $3,030 |
Brand drugs: 840 claims; generic drugs: 7,076 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harpaul Bajwa $3,439 ($3,439 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbott Laboratories with $2,900.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 13 | $2,900 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $163 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $144 |
| BridgeBio Pharma, Inc. BBIO | 2 | $55.58 |
| Heartflow, Inc. HTFL | 3 | $42.64 |
| Baxter Healthcare BAX | 1 | $31.78 |
| Abiomed JNJ | 1 | $28.32 |
| Boston Scientific Corporation BSX | 1 | $24.77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19.57 |
| Pfizer Inc. PFE | 1 | $14.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.